HPV Vaccine Price 2025: Unveiling the Cost Disparity
HPV Vaccine Pricing: A Costly Conundrum The Human Papillomavirus (HPV) vaccine, a crucial preventative measure against cervical cancer and other related diseases, presents a significant pricing puzzle in South Africa. A stark discrepancy exists between the cost secured by the government and the price paid by individuals in the private sector. This article analyses this disparity, explores the contributing factors, and proposes actionable recommendations for all stakeholders involved. Understanding this cost difference is vital for ensuring equitable access to this life-saving vaccine for all South Africans....